Filing Details

Accession Number:
0001209191-14-063274
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-15 13:58:55
Reporting Period:
2014-10-13
Filing Date:
2014-10-15
Accepted Time:
2014-10-15 13:58:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1415336 Zeltiq Aesthetics Inc ZLTQ Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529196 J Mark Foley 4698 Willow Road
Suite 100
Pleasanton CA 94588
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-10-13 29,869 $21.29 616,822 No 4 F Direct
Common Stock Disposition 2014-10-13 4,666 $21.29 612,156 No 4 F Direct
Common Stock Disposition 2014-10-14 6,319 $21.56 605,837 No 4 S Direct
Common Stock Disposition 2014-10-14 804 $21.96 605,033 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the number of shares withheld by and surrendered to the Issuer on October 13, 2014, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU grant on August 23, 2012 of 286,215 shares. The initial grant vests in five equal installments, each on the first date that the weighted average stock price of ZELTIQ Common Stock during the immediately preceding 90-day period is $10 or more, $15 or more, $20 or more, $25 or more, and $30 and more, respectively.
  2. Represents the number of shares withheld by and surrendered to the Issuer on October 13, 2014, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU granted on August 23, 2012 for 429,333 shares. The RSU vested with respect to 25% of the underlying shares on October 13, 2013 and the remaining shares shall vest monthly thereafter in 36 equal installments.
  3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 17, 2014.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.91 to $21.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.93 to $22.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.